Sunday, March 15, 2026

A Retro-[1,4]-aza-Brook Rearrangement

It's well documented that silyl group has a tendency to migrate to the neighboring location as long as the geometry favors the move. The retro-[1,4]-aza-Brook rearrangement is a chemical transformation involving the intramolecular migration of a silyl group from a nitrogen atom to a carbon atom. It is the reverse process of the [1, 4]-aza Brook rearrangement, which typically migrates silicon from carbon to nitrogen. During my graduate study, an 1, 4-N to C anionic migration was observed, in which the Me3Si group on the allylic amine nitrogen underwent an intramolecular migration to the vinylic carbon anion generated by transmetallation of Bu3Sn group that has a Z-configuration ( Corriu and Geng et al: J. Org. Chem., 1993, 58 , 1443). It could be envisioned that the silyl group migrates via a pentacoordinated silicon intermediate. In contrast, the trans configured N, N-bis(Me3Si)-E-Bu3Sn substituted allylic amine gives no such migration upon lithiation, which confirmed the steric requirement. 


 


A similar 1, 4-N to C anionic migration was recognized by an Italian group a bit earlier (Ricci et al: Synlett., 1991, 712). In this case the allylic anion was produced by deprotonating the allylic C-H in N, N-bis(Me3Si)-E-Me3Si substituted allylic amine. Interestingly, over three decades later, these remain as the only two examples of 1, 4-N to C-silyl migration. During the last 30 years, a number of other 1, 4-silyl migrations have been reported, such as, from O to C ( Mitchell et al: Tet. Lett., 1999, 55, 1285; Lautens et al: J. Org. Chem., 1992, 57, 3270), from C to O (Takeda et al: Chem. Commun., 2002, 2218) and from C to C (Kawachi et al: Organometallics, 2006, 252390). All these 1,4-silyl migrations will eventually find interesting synthetic applications.

Sunday, December 28, 2025

Two FDA-approved Drug Molecules Discovered at University of Montpellier, and the Third One is Coming along

1. Macrilen (Macimorelin): CAS [381231-18-1], FDA-approved (December 2017) used to diagnose growth hormone deficiency. From Professor Jean Martinez's Lab. 2.Tyzeka in USA,Sebivo in Europe,(Telbivudine), CAS [3424-98-4], FDA-approved (October 2006), is an antiviral drug used in the treatment of hepatitis B infection. From Professors Jean-louis Imbach and Gilles Gosselin's Lab. 3.Obefazimod, CAS [1258453-75-6], Phase III completed, is an investigational new drug that is being evaluated for the treatment of ulcerative colitis. From Professor Jamal Tazi's Lab.

Tuesday, January 10, 2023

In Memory of Professor Zhou Xiuzhong 周秀中 (1924-2023)

 

 

Professor Zhou (1924-2023) has made many great contributions to organic chemistry and China's silicon industry. An absolutely outstanding teacher, mentor, advisor, friend, and above all, a genuinely great human being. He will be missed by all his students over a 70 yrs career! Shown above is a tiny, tiny piece of his early works to demonstrate his insight in Si-N bond stability. 

RIP, Dear Prof ZHOU! 

____

Prof. Zhou Xiuzhong (b.1924), BS, Hunan University (1947-1951), Post Graduate, Peking University (1951-1953), Visiting Scholar, UMass and Northwestern University (1981-1982), Professor, Nankai University (1953-2023)

   

Thursday, September 1, 2022

Beta-Lactamase Inhibitors

From my early work on Penicillin-based Sulfones (SMU, BMCL, 1995, 5, 1513-18, ) to the more recent DABCO Durlobactam (AZD2514/ETX2514) (AstraZeneca, WO2013150296 (US 9,309,245, US 9,623,014)a full circle!